Dynavax to Participate in Two Upcoming Investor Conferences
(firmenpresse) - BERKELEY, CA -- (Marketwired) -- 09/03/15 -- Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that the company will participate in two investor conferences next week. Dynavax's presentation at the Newsmakers in the Biotech Industry Conference will occur in New York City on September 10, 2015 at 8:30 a.m. EDT. This presentation will be webcast live. Dynavax will also participate in the FBR Second Annual Healthcare Conference in Boston on September 9th, which will not be webcast.
The live or replayed versions of the webcast of the Newsmakers presentation will be available by visiting the "Investors" section of the Dynavax website or may be reached directly at:
Dynavax, a clinical-stage biopharmaceutical company, uses TLR biology to discover and develop novel vaccines and therapeutics in the areas of infectious and inflammatory diseases and oncology. Dynavax's lead product candidates are HEPLISAV-B™, a Phase 3 investigational adult hepatitis B vaccine, and SD-101, an investigational cancer immunotherapeutic currently in several Phase 1/2 studies. For more information visit .
Michael Ostrach
Chief Financial Officer
510-665-7257
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.09.2015 - 13:00 Uhr
Sprache: Deutsch
News-ID 417886
Anzahl Zeichen: 0
contact information:
Town:
BERKELEY, CA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 163 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Dynavax to Participate in Two Upcoming Investor Conferences"
steht unter der journalistisch-redaktionellen Verantwortung von
Dynavax Technologies (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
